Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

RARERARE
Showing 8 of 30 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ULTRAGENYX PHARMACEUTICAL IN

GEODE CAPITAL MANAGEMENT, LLC holds 1.8M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $38.8M as of 2026-Q1. The position was increased (+0.6% shares). RARE represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$38.8M

Current Shares

1.8M

Total Value Change

-$23.1M

Total Shares Change

+343,933

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.8M
+0.6%
$38.8M0.0%$22.07
29
2025-Q4
Increased
1.8M
+16.3%
$42.3M0.0%$22.78
34
2025-Q3
Decreased
1.6M
-7.7%
$47.6M0.0%$30.36
0
2025-Q2
Increased
1.7M
+4.0%
$62.3M0.0%$36.52
31
2025-Q1
Increased
1.6M
+5.4%
$59.6M0.0%$37.82
31
2024-Q4
Decreased
1.6M
-0.5%
$65.8M0.0%$42.27
0
2024-Q3
Increased
1.6M
+4.4%
$87.3M0.0%$54.43
31
2024-Q2
Increased
1.5M
+12.4%
$61.9M0.0%$41.10
33

Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used